CC BY 4.0 · Glob Med Genet 2022; 09(02): 057-059
Quantitative In Vivo Genetic Analysis Reveals Novel Genetic Determinants of Tumor Initiation, Overall Growth, and Exceptional Growth in KRAS-Driven Lung Cancer
Ji Ruan
1
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China
› Author Affiliations
Reference
1
Siegel RL,
Miller KD,
Jemal A.
Cancer statistics, 2020. CA Cancer J Clin 2020; 70 (01) 7-30
2
Feng RM,
Zong YN,
Cao SM,
Xu RH.
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?. Cancer Commun (Lond) 2019; 39 (01) 22
3
Cao M,
Li H,
Sun D,
Chen W.
Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun (Lond) 2020; 40 (05) 205-210
4
Hanahan D,
Weinberg RA.
Hallmarks of cancer: the next generation. Cell 2011; 144 (05) 646-674
5
Consortium APG.
AACR Project GENIE Consortium.
AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov 2017; 7 (08) 818-831
6
Wu Y,
Liu Z,
Xu X.
Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine. Cancer Commun (Lond) 2020; 40 (12) 681-693
7
Zhang Y,
Chang L,
Fang W.
et al.
Preferable background filtering for next-generation sequencing analysis in non-small cell lung cancer: pericarcinomatous tissues or peripheral blood lymphocytes?. Cancer Commun (Lond) 2019; 39 (01) 33
8
Lawrence MS,
Stojanov P,
Polak P.
et al.
Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013; 499 (7457): 214-218
9
Greaves M,
Maley CC.
Clonal evolution in cancer. Nature 2012; 481 (7381): 306-313
10
Winters IP,
Murray CW,
Winslow MM.
Towards quantitative and multiplexed in vivo functional cancer genomics. Nat Rev Genet 2018; 19 (12) 741-755
11
Ben-David U,
Beroukhim R,
Golub TR.
Genomic evolution of cancer models: perils and opportunities. Nat Rev Cancer 2019; 19 (02) 97-109
12
Kersten K,
de Visser KE,
van Miltenburg MH,
Jonkers J.
Genetically engineered mouse models in oncology research and cancer medicine. EMBO Mol Med 2017; 9 (02) 137-153
13
Sánchez-Rivera FJ,
Papagiannakopoulos T,
Romero R.
et al.
Rapid modelling of cooperating genetic events in cancer through somatic genome editing. Nature 2014; 516 (7531): 428-431
14
Rogers ZN,
McFarland CD,
Winters IP.
et al.
A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo. Nat Methods 2017; 14 (07) 737-742
15
Cai H,
Chew SK,
Li C.
et al.
A functional taxonomy of tumor suppression in oncogenic KRAS-driven lung cancer. Cancer Discov 2021; 11 (07) 1754-1773
16
Ciriello G,
Cerami E,
Sander C,
Schultz N.
Mutual exclusivity analysis identifies oncogenic network modules. Genome Res 2012; 22 (02) 398-406
